LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,195 | -37.4% | 31,372 | +31.5% | 0.00% | – |
| Q2 2023 | $54,626 | +2.8% | 23,854 | +9.1% | 0.00% | – |
| Q1 2023 | $53,151 | +30.6% | 21,873 | +2.7% | 0.00% | – |
| Q4 2022 | $40,685 | -15.2% | 21,301 | +6.7% | 0.00% | – |
| Q3 2022 | $48,000 | +60.0% | 19,957 | +23.1% | 0.00% | – |
| Q2 2022 | $30,000 | -11.8% | 16,216 | +0.7% | 0.00% | – |
| Q1 2022 | $34,000 | -44.3% | 16,100 | +3.5% | 0.00% | – |
| Q4 2021 | $61,000 | -19.7% | 15,554 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $76,000 | +5.6% | 15,732 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +227.3% | 15,696 | +39.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $42,694,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $575,754,000 | 8.68% |
| SECTOR GAMMA AS | 837,192 | $8,271,000 | 1.39% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $353,000 | 1.36% |
| Virtus ETF Advisers LLC | 95,079 | $939,000 | 1.18% |
| NEA Management Company, LLC | 2,382,286 | $23,537,000 | 0.98% |
| USS Investment Management Ltd | 3,507,900 | $34,676,000 | 0.40% |
| Malaga Cove Capital, LLC | 59,387 | $587,000 | 0.33% |
| CLEARBRIDGE, LLC | 1,189,097 | $11,748,000 | 0.24% |
| WEDBUSH SECURITIES INC | 139,106 | $1,374,000 | 0.17% |